NeoGenomics
NEO
$13.53
Share price
-1.74%
Change (1 day)
-14.85%
Change (1 year)
Operating Margin for NeoGenomics (NEO)
Operating Margin as of April 2024 (TTM): -31.26%
According to NeoGenomics 's latest financial reports and stock price the company's current Operating Margin is -31.26%. At the end of 2022 the company had an Operating Margin of -31.26%.
Operating Margin history for NeoGenomics from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -31.26% | 904.33% |
| 2021 | -3.11% | -1.58% |
| 2020 | -3.16% | -454.72% |
| 2019 | 0.89% | -35.48% |
| 2018 | 1.38% | -202.66% |
| 2017 | -1.35% | -55.75% |
| 2016 | -3.04% | -32.38% |
| 2015 | -4.50% | -403.82% |
| 2014 | 1.48% | -54.97% |
| 2013 | 3.29% | 2927.75% |
| 2012 | 0.11% | -111.54% |
| 2011 | -0.94% | -89.09% |
| 2010 | -8.62% | 47.06% |
| 2009 | -5.86% | 32.73% |
| 2008 | -4.42% | -83.82% |
| 2007 | -27.30% | -1362.95% |
| 2006 | 2.16% | -105.09% |
| 2005 | -42.45% | -67.53% |
| 2004 | -130.73% | -2.16% |
| 2003 | -133.61% | -78.6% |
| 2002 | -624.31% | -99.92% |
| 2001 | -807,796.60% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | 11.10% | -135.51% | 🇺🇸 USA |
 LabCorp LH | 10.63% | -134.01% | 🇺🇸 USA |
 RadNet RDNT | 3.00% | -109.60% | 🇺🇸 USA |
 Psychemedics PMD | -4.12% | -86.82% | 🇺🇸 USA |
 Enzo Biochem ENZ | -43.44% | 38.96% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.